[ Price : $8.95]
Federal Register notice: FDA classifies the organophosphate test system into Class 2 (special controls).[ Price : $8.95]
FDA grants a Public Citizen petition to ban cornstarch powder in surgeons and patient examination gloves and denies its request to...[ Price : $8.95]
A Health Affairs blog post raises several questions about major policy changes in the FDA Digital Health Innovation Action Plan.[ Price : $8.95]
Public Citizen says that former Lilly executive Alex Azar, a potential candidate as HHS secretary, opposes steps to restrain drug ...[ Price : $8.95]
Media resource CMI says YouTube bumper ads can be used strategically to tease new products, increase awareness of existing product...[ Price : $8.95]
After 28 years at FDA, CDER Office of Process and Facilities (OPF) acting deputy director David Doleski leaves to accept the posit...[ Price : $8.95]
FDA accepts for priority review an AstraZeneca supplemental NDA for the use of Lynparza (olaparib) tablets in certain patients wit...[ Price : $8.95]
FDA releases two identical FDA-483s issued to Akorn, Inc., with three inspection observations.